Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Haoyun Pharmaceutical is a comprehensive pharmaceutical enterprise based in Chengdu, China, specializing in the research, production, and sales of chemical drugs. The company focuses on high-end generic medications and the development of innovative Class 1 small molecule drugs, particularly in the fields of oncology and metabolic health. With a significant presence in the Chengdu Medical City, it operates integrated R&D and GMP-compliant manufacturing facilities for both active pharmaceutical ingredients (APIs) and finished formulations. Haoyun Pharmaceutical aims to bridge the gap between advanced chemical synthesis and clinical needs within the Chinese domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Haoyun Pharmaceutical.